MedTrace Logo

FAST as a Treatment for Obstructive Sleep Apnea

NCT01611779 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2017-02-24

Study results available
· View outcomes & findings →

Summary

The objective of this study is to assess the feasibility and safety of tongue suspension using the Siesta Medical Encore Tongue Suspension System for the treatment of obstructive sleep apnea (OSA).

Conditions

Interventions

DEVICE

Encore Tongue Suspension System

The primary components of the Encore Tongue Suspension System consist of a suture passer, suspension line and bone screw.

Sponsors & Collaborators

  • Siesta Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Andrew Goldberg, MD · University of California, San Francisco

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01611779 on ClinicalTrials.gov